Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lisdexamfetamine in Binge Eating Disorder of Moderate or Greater Severity

NCT01090713 is registered in ClinicalTrials.gov with Lindner Center of HOPE as lead sponsor.

NCT NCT01090713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01090713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lisdexamfetamine in Binge Eating Disorder of Moderate or Greater Severity
Lead sponsor
Lindner Center of HOPE
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2010
Completion date
October 31, 2012
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

binge eating disorder